BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28505106)

  • 1. Human Chorionic Gonadotropin: The Pregnancy Hormone and More.
    Theofanakis C; Drakakis P; Besharat A; Loutradis D
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28505106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
    Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
    Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
    Kim CH; Ahn JW; You RM; Kim SH; Chae HD; Kang BM
    J Reprod Med; 2014; 59(1-2):63-8. PubMed ID: 24597289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
    Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant-LH and hCG in the absence of FSH on in vitro maturation (IVM) fertilization and early embryonic development of mouse germinal vesicle (GV)-stage oocytes.
    Dinopoulou V; Drakakis P; Kefala S; Kiapekou E; Bletsa R; Anagnostou E; Kallianidis K; Loutradis D
    Reprod Biol; 2016 Jun; 16(2):138-46. PubMed ID: 27288338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: A Systematic Review and Meta-analysis.
    Ding N; Liu X; Jian Q; Liang Z; Wang F
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():92-98. PubMed ID: 28957685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Triggering With Gonadotropin-Releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate.
    Fabris AM; Cruz M; Legidos V; Iglesias C; Muñoz M; García-Velasco JA
    Reprod Sci; 2017 Aug; 24(8):1221-1225. PubMed ID: 28715965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
    European Recombinant LH Study Group
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles.
    Choi J; Smitz J
    Gynecol Endocrinol; 2014 Mar; 30(3):174-81. PubMed ID: 24283620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic understanding of gonadotropin-releasing hormone-agonist triggering.
    Casper RF
    Fertil Steril; 2015 Apr; 103(4):867-9. PubMed ID: 25712575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles.
    Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Ross R
    Fertil Steril; 2007 Jul; 88(1):237-9. PubMed ID: 17296193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
    Ge HS; Huang XF; Zhang W; Zhao JZ; Lin JJ; Zhou W
    Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles.
    Seval MM; Özmen B; Atabekoğlu C; Şükür YE; Şimşir C; Kan Ö; Sönmezer M
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1146-51. PubMed ID: 27199084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration.
    Propst AM; Hill MJ; Bates GW; Palumbo M; Van Horne AK; Retzloff MG
    Fertil Steril; 2011 Oct; 96(4):898-904. PubMed ID: 21839437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of variant luteinizing hormone/chorionic gonadotropin receptors and degradation of chorionic gonadotropin in human chorionic villous macrophages.
    Sonoda N; Katabuchi H; Tashiro H; Ohba T; Nishimura R; Minegishi T; Okamura H
    Placenta; 2005 Apr; 26(4):298-307. PubMed ID: 15823616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of LH and FSH receptors after hCG and eCG treatments in the porcine oviduct.
    Małysz-Cymborska I; Andronowska A
    Domest Anim Endocrinol; 2016 Oct; 57():48-54. PubMed ID: 27565230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between in vitro maturation and expression of LH receptor in cumulus cells of the oocytes collected from PCOS patients in HCG-primed IVM cycles.
    Yang SH; Son WY; Yoon SH; Ko Y; Lim JH
    Hum Reprod; 2005 Aug; 20(8):2097-103. PubMed ID: 15878924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.